Psychoeducational Programme for PD Patients With STN-DBS (PSYCHE)

September 17, 2015 updated by: Marie-laure Welter, Groupe Hospitalier Pitie-Salpetriere

Psychoeducational Programme for Patients With Parkinson's Disease Undergoing Subthalamic Deep Brain Stimulation

Bilateral subthalamic deep-brain stimulation is a well-established therapeutic option to improve motor signs and reduce dopaminergic treatment and related motor complications in patients with severe forms of Parkinson's disease (PD). However, psychological disorders and socio-familial maladjustment are less clearly improved with subthalamic stimulation with an aggravation of the social adjustment described in about 1/3 of cases, with work disruption, divorce or familial conflict. The caregivers have also been reported to present negative well-being after surgery with an aggravation of the quality of life. In the present study, the investigators evaluate the effects of a perioperative psychoeducational programme to avoid postoperative socio-familial maladjustment in PD patients candidate for subthalamic stimulation, and their caregivers, in a randomized controlled study.

Study Overview

Status

Completed

Conditions

Detailed Description

After inclusion, patients (and their caregivers) are randomized into two groups stratified on their preoperative social adjustment scale couple domain score : usual treatment and psychoeducational programme or usual treatment alone (Figure). The psychoeducational programme focuses on 3 domains: 1) neurosurgical procedure and neurological outcome, 2) social life including work, social and familial relationship, 3) couple relationship. The programme consists of 7 sessions with 3 to 4 couples at the same session, except for the 'couple relationship' domain. Each domain is tackled in a two-way manner with information/education proved by the investigator and discussion of the patients' and caregivers' expectations during one session. The following session started with a 'Questions and Answers' on the previous domain and then information on another domain. Four sessions were carried out prior to surgery and 3 after.

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Paris, France, 75013
        • Centre d'Investigation Clinique GHPS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Parkison's disease
  • Patients candidate for STN DBS
  • Caregiver agreeing to participate
  • Signed informed consent

Exclusion Criteria:

  • Contra-indication to STN-DBS
  • No caregiver agreeing to participate
  • Dementia
  • Severe ongoing psychiatric disorder

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Psychoeducational programme
4 sessions of psychoeducation before and 3 after surgery for subthalamic deep brain stimulation
No Intervention: Usual care
No psychoeducational programme

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Social adjustment scale
Time Frame: Change from baseline at 1 year after surgery
Change from baseline at 1 year after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Parkinson's disease Questionnaire PDQ-39
Time Frame: Change from baseline at 1 and 2 years after surgery
Quality of life
Change from baseline at 1 and 2 years after surgery
Anxiety scale (STAI)
Time Frame: Change from baseline at 1 and 2 years after surgery
STAI
Change from baseline at 1 and 2 years after surgery
Mattis dementia rating scale
Time Frame: Change from baseline at 1 and 2 years after surgery
mattis dementia rating scale
Change from baseline at 1 and 2 years after surgery
Parkinsonian disability (Unified Parkinson's Disease Rating Scale)
Time Frame: Change from baseline at 1 and 2 years after surgery
Unified Parkinson's Disease Rating Scale
Change from baseline at 1 and 2 years after surgery
Dopaminergic treatment dosage (mg/day)
Time Frame: Change from baseline at 1 and 2 years after surgery
Daily dosage of dopaminergic agents
Change from baseline at 1 and 2 years after surgery
Social adjustment scale
Time Frame: Change from baseline at 2 years after surgery
Change from baseline at 2 years after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Yannick Vacher, APHP

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2008

Primary Completion (Actual)

September 1, 2013

Study Completion (Actual)

June 1, 2015

Study Registration Dates

First Submitted

September 15, 2015

First Submitted That Met QC Criteria

September 17, 2015

First Posted (Estimate)

September 18, 2015

Study Record Updates

Last Update Posted (Estimate)

September 18, 2015

Last Update Submitted That Met QC Criteria

September 17, 2015

Last Verified

September 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Parkinson's Disease

Clinical Trials on Psychoeducational programme

Subscribe